HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Laia Alsina Selected Research
Laia Alsina Research Topics
Disease
8
Infections
01/2022 - 07/2011
4
Inflammation (Inflammations)
01/2021 - 11/2010
2
Atopic Dermatitis (Atopic Eczema)
01/2021 - 09/2015
2
Lymphopenia (Lymphocytopenia)
01/2021 - 11/2012
2
Neoplasms (Cancer)
01/2021 - 07/2018
2
Herpes Simplex Encephalitis (Herpes Encephalitis)
11/2019 - 01/2018
2
Autoimmune Diseases of the Nervous System
11/2019 - 01/2018
2
Persistent Infection
07/2018 - 05/2013
2
Reinfection
01/2018 - 01/2015
2
Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2017 - 09/2015
2
Sepsis (Septicemia)
02/2016 - 01/2013
2
Virus Diseases (Viral Diseases)
09/2015 - 12/2010
2
Pneumococcal Infections
09/2015 - 11/2010
2
Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome)
11/2012 - 07/2011
1
Primary Immunodeficiency Diseases
04/2022
1
COVID-19
01/2022
1
Cytopenia
01/2022
1
Central Nervous System Vasculitis
01/2022
1
Noonan Syndrome (Female Pseudo-Turner Syndrome)
01/2022
1
Congenital Disorders of Glycosylation
01/2022
1
Asthma (Bronchial Asthma)
04/2021
1
Cytokine Release Syndrome
01/2021
1
Dermatitis
01/2021
1
Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2021
1
Measles
01/2021
1
Mumps
01/2021
1
Mycoses (Diseases, Fungus)
01/2021
1
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (Congenital Disorders)
01/2021
1
Rubella (German Measles)
01/2021
1
B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2021
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2021
1
Macrophage Activation Syndrome
01/2021
1
Bacterial Meningitis
09/2020
1
Dysgammaglobulinemia
01/2020
1
Lung Diseases (Lung Disease)
01/2018
1
Common Variable Immunodeficiency
01/2018
1
Kabuki syndrome
01/2018
1
Seizures (Absence Seizure)
01/2018
1
Tuberculosis (Tuberculoses)
01/2018
1
Agammaglobulinemia (Hypogammaglobulinemia)
01/2018
1
Obesity
01/2017
1
Hypersensitivity (Allergy)
01/2017
1
Critical Illness (Critically Ill)
02/2016
1
Job Syndrome (Hyper-IgE Syndrome)
09/2015
1
Candidiasis (Moniliasis)
09/2015
1
Abscess
09/2015
1
Tyrosine Kinase 2 Deficiency
09/2015
1
Cerebrospinal Fluid Leak
01/2015
1
Human Influenza (Influenza)
04/2013
Drug/Important Bio-Agent (IBA)
4
Cytokines
IBA
01/2022 - 01/2013
4
Immunoglobulin E (IgE)
IBA
01/2021 - 09/2012
3
Immunoglobulins (Immunoglobulin)
IBA
04/2022 - 01/2018
3
Vaccines
IBA
01/2021 - 07/2011
2
Sirolimus (Rapamycin)
FDA Link
01/2022 - 01/2018
2
Interleukin-12 (IL 12)
IBA
01/2017 - 09/2015
2
Interferons
IBA
04/2013 - 12/2010
1
Glycoproteins (Glycoprotein)
IBA
01/2022
1
Adrenal Cortex Hormones (Corticosteroids)
IBA
01/2022
1
phosphomannomutase
IBA
01/2022
1
Abatacept (Orencia)
FDA Link
01/2022
1
Rituximab (Mabthera)
FDA Link
01/2022
1
fludarabine
IBA
01/2021
1
Chimeric Antigen Receptors
IBA
01/2021
1
Azoles
IBA
01/2021
1
Cyclophosphamide (Cytoxan)
FDA Link
Generic
01/2021
1
Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)
IBA
01/2021
1
Chemokine CCL5
IBA
01/2021
1
Interleukin-18 (Interleukin 18)
IBA
01/2021
1
Interleukin-27 (Interleukin 27)
IBA
01/2021
1
eculizumab
FDA Link
09/2020
1
Toll-Like Receptor 3
IBA
11/2019
1
BCG Vaccine
FDA Link
01/2018
1
Antigens
IBA
01/2018
1
Antibodies
IBA
01/2018
1
N-Methyl-D-Aspartate Receptors (NMDA Receptors)
IBA
01/2018
1
Adalimumab (Humira)
FDA Link
01/2017
1
Infliximab (Remicade)
FDA Link
01/2017
1
Glutamine (L-Glutamine)
FDA Link
02/2016
1
HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)
IBA
02/2016
1
Congenital disorder of glycosylation type 1A
IBA
01/2016
1
Interleukin-6 (Interleukin 6)
IBA
09/2015
1
Interleukin-23 (Interleukin 23)
IBA
09/2015
1
Interleukin-10 (Interleukin 10)
IBA
09/2015
1
Toll-Like Receptors (Toll-Like Receptor)
IBA
09/2015
1
DNA (Deoxyribonucleic Acid)
IBA
01/2015
1
Phosphotransferases (Kinase)
IBA
12/2014
1
Tetanus Toxoid (Vaccine, Tetanus)
FDA Link
05/2013
1
Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)
IBA
04/2013
1
Polymyxin B (Aerosporin)
FDA Link
Generic
01/2013
Therapy/Procedure
4
Therapeutics
01/2022 - 01/2013
1
Splenectomy
01/2022
1
Biological Therapy
04/2021
1
Cell- and Tissue-Based Therapy (Cell Therapy)
01/2021
1
Retreatment
01/2020
1
Transplantation
07/2018
1
Aftercare (After-Treatment)
01/2018
1
Mediterranean Diet
01/2017
1
Parenteral Nutrition
02/2016
1
Drug Therapy (Chemotherapy)
01/2015
1
Immunomodulation
01/2013